Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
leuprorelin
(CKD-841) /
Chong Kun Dang
Welcome,
Profile
Billing
Logout
0 Diseases
1 Trial
1 Trial
1 News
||
||||||||
leuprorelin
(CKD-841) /
Chong Kun Dang
New P1 trial:
The Safety and Pharmacokinetic/Pharmacodynamic Study of CKD-841 in Postmenopausal Female, Phase 1
(clinicaltrials.gov) - Apr 12, 2021
P1
, N=32, Not yet recruiting,
Sponsor: Chong Kun Dang Pharmaceutical